Cigna Corp (CI)

Profitability ratios

Return on sales

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit margin 88.39% 83.63% 82.80% 82.04% 81.42% 85.78% 86.11% 86.32% 86.54% 86.51% 86.11% 85.77% 85.71% 135.89% 136.56% 138.27% 138.72% 138.70% 139.75% 139.57%
Operating profit margin 3.43% 3.67% 4.15% 4.30% 4.37% 4.32% 4.36% 4.51% 4.68% 4.58% 4.68% 4.61% 4.55% 4.54% 4.52% 4.93% 5.08% 5.33% 5.42% 5.13%
Pretax margin 2.15% 1.49% 1.90% 1.95% 2.82% 3.50% 4.46% 4.60% 4.65% 4.64% 3.86% 3.86% 3.89% 6.37% 6.34% 6.73% 6.77% 4.30% 4.34% 4.01%
Net profit margin 1.40% 1.32% 1.72% 1.77% 2.65% 2.79% 3.58% 3.69% 3.71% 3.68% 3.06% 3.05% 3.08% 4.92% 4.88% 5.17% 5.27% 3.38% 3.40% 3.19%

Based on the provided data, the profitability ratios of Cigna Corp have shown some fluctuations over the reporting periods.

1. Gross Profit Margin: The gross profit margin, which measures the percentage of revenue that exceeds the cost of goods sold, ranged from a high of around 139% in early 2020 to a low of 81% by the end of 2023 before recovering to around 88% by the end of 2024.

2. Operating Profit Margin: The operating profit margin, indicating the company's efficiency in generating profits from its core operations, fluctuated from approximately 5% in early 2020 to a low of 3.4% by the end of 2024.

3. PreTax Margin: The pre-tax margin, reflecting the proportion of earnings before taxes in comparison to revenue, was around 4.3% in mid-2020 before declining to approximately 1.5% by the end of 2024.

4. Net Profit Margin: The net profit margin, showing the percentage of revenue that translates into profit after all expenses, varied from about 3.2% in early 2020 to a low of 1.3% by the end of 2024.

Overall, Cigna Corp experienced fluctuations in its profitability margins over the analyzed periods, with declines in margins towards the end of the period. It is essential for the company to focus on improving operational efficiency and cost management to sustain and enhance its profitability in the future.


Return on investment

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating return on assets (Operating ROA) 5.39% 5.37% 5.94% 5.91% 5.77% 5.48% 5.40% 5.58% 5.85% 5.71% 5.50% 5.35% 5.12% 5.02% 4.90% 5.29% 5.24% 5.23% 5.25% 5.11%
Return on assets (ROA) 2.20% 1.93% 2.46% 2.44% 3.49% 3.54% 4.43% 4.56% 4.64% 4.60% 3.60% 3.54% 3.46% 5.44% 5.29% 5.55% 5.44% 3.31% 3.30% 3.18%
Return on total capital 20.69% 15.26% 16.59% 16.33% 14.15% 17.20% 21.36% 22.09% 22.18% 22.02% 18.19% 17.63% 16.59% 24.44% 23.41% 24.46% 23.20% 16.39% 16.68% 16.26%
Return on equity (ROE) 8.37% 7.22% 8.97% 8.79% 11.17% 11.61% 14.64% 15.17% 14.89% 14.71% 11.97% 11.72% 11.39% 17.68% 16.73% 17.52% 16.81% 11.03% 11.11% 10.91%

Cigna Corp's profitability ratios show a mixed performance over the quarters. The Operating Return on Assets (Operating ROA) has displayed a slightly increasing trend from 5.11% as of March 2020 to 5.39% as of December 2024, indicating a generally stable operational efficiency in generating profits relative to its total assets.

Similarly, the Return on Assets (ROA) ratio varied significantly over time, ranging from 1.93% as of September 2024 to 5.55% as of March 2021. This inconsistency in ROA suggests fluctuations in the company's ability to generate profits from its total assets during the period under consideration.

The Return on Total Capital ratio peaked at 24.46% as of March 2021 but declined thereafter, reaching 20.69% as of December 2024. This metric highlights the company's ability to generate returns for both equity and debt capital providers, with a gradual decreasing trend during the latter part of the period.

Lastly, the Return on Equity (ROE) showed a similar declining trend from 17.68% as of September 2021 to 8.37% as of December 2024. This indicates a decreasing ability to generate profits for the equity shareholders as the profitability from owners' investments diminished over the quarters.

In conclusion, although Cigna Corp maintained a stable Operating ROA and exhibited fluctuations in ROA, the Return on Total Capital and ROE ratios experienced a decreasing trend, suggesting challenges in efficiently utilizing both equity and debt capital to generate profits for shareholders.


See also:

Cigna Corp Profitability Ratios (Quarterly Data)